Results 11 to 20 of about 65,085 (140)
Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients. [PDF]
PLoS ONE, 2018 BACKGROUND:Proton pump inhibitor use is associated with incident chronic kidney disease, chronic kidney disease progression and end-stage renal disease.
Hee Jeong Lee +8 more
doaj +1 more source
Journal of Medical Case Reports, 2021 Background Proton pump inhibitors are frequently used (and often overused) medications with adverse effects including vitamin B12 deficiency, Clostridium difficile colitis, and increased risk of chronic kidney disease.
Theodore W. Perry
doaj +1 more source
Proton pump inhibitors and gastroenteritis [PDF]
, 2016 An association between proton pump inhibitor (PPI) therapy and bacterial gastroenteritis has been suggested as well as contradicted. The aim of this study was to examine the association between the use of PPIs and occurrence of bacterial gastroenteritis ...
de Visser, H. (Herman) +4 more
core +7 more sources
Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A meta-analysis [PDF]
, 2005 Aim: To systematically evaluate the efficacy of H2-receptor antagonists (H2RAs) and proton pump inhibitors in healing erosive esophagitis (EE). Methods: A meta-analysis was performed.
Huang, JQ +6 more
core +1 more source
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease [PDF]
, 2016 Background Acute interstitial nephritis secondary to proton pump inhibitors (PPIs) frequently goes undiagnosed due to its subacute clinical presentation, which may later present as chronic kidney disease (CKD).
Arora, Pradeep +6 more
core +2 more sources
World Chinese Journal of Digestology, 2013 Proton pump inhibitors (PPIs), omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole, and dexlansoprazole bind irreversibly to the H+, K+- ATPase (the “proton pump”) inhibiting its activity and decreasing gastric acid production.
Jie-Hao Zhou, Bing-Rong Liu
openaire +2 more sources
Risk of Bacterial Infection from Proton Pump Inhibitor Use
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2017 Currently, proton pump inhibitors are used in a wide range of patients with gastroesophageal reflux disease, peptic ulcer, and upper gastrointestinal symptoms such as dyspepsia.
Sung Soo Kim +7 more
doaj +1 more source
Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
Gastroenterology Research and Practice, 2015 In 2006, hypomagnesemia was first described as a complication of proton-pump inhibitors. To address this issue, we systematically reviewed the literature.
Simone Janett +7 more
doaj +1 more source
Critical Care Explorations, 2021 OBJECTIVES:. Histamine-2 receptor antagonists are commonly administered for stress ulcer prophylaxis in critically ill adults and may be associated with delirium development.
Ami Shiddapur, BS +3 more
doaj +1 more source
Gut, 2000 Proton Pump Inhibitors . Edited by Olbe L. (Pp 264; illustrated; sFr198.00.) Switzerland: Birkhauser Verlag. 1999. ISBN 3 76435 897 1. The history of the development of drugs to treat the so-called acid related diseases makes a fascinating story, and the publication of this book addresses a significant chapter in that story.
openaire +3 more sources